List of Excipients in API diazoxide oral suspension
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing diazoxide oral suspension
Detailed excipient profiles for diazoxide oral suspension
Excipient focus: ALCOHOL
diazoxide oral suspension drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
diazoxide oral suspension drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
diazoxide oral suspension drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
diazoxide oral suspension drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
diazoxide oral suspension drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
diazoxide oral suspension drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM ALUMINUM SILICATE
diazoxide oral suspension drug variants containing MAGNESIUM ALUMINUM SILICATE
| Company | Ingredient | NDC |
|---|---|---|
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
diazoxide oral suspension drug variants not containing MAGNESIUM ALUMINUM SILICATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
diazoxide oral suspension drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
diazoxide oral suspension drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
diazoxide oral suspension drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
diazoxide oral suspension drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE OXIDE
diazoxide oral suspension drug variants containing PROPYLENE OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
diazoxide oral suspension drug variants not containing PROPYLENE OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
diazoxide oral suspension drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
diazoxide oral suspension drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
diazoxide oral suspension drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
diazoxide oral suspension drug variants not containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL SOLUTION 70%
diazoxide oral suspension drug variants containing SORBITOL SOLUTION 70%
| Company | Ingredient | NDC |
|---|---|---|
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
diazoxide oral suspension drug variants not containing SORBITOL SOLUTION 70%
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
